What is the typical dosing regimen for mirtazapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine Dosing Regimen

The recommended dosing regimen for mirtazapine is to start with 15 mg once daily administered orally in the evening prior to sleep, with dose increases up to a maximum of 45 mg per day if needed, allowing 1-2 weeks between dose adjustments to evaluate response. 1

Initial Dosing and Titration

  • Start with 15 mg once daily, preferably in the evening prior to sleep 1
  • If inadequate response occurs, increase the dose after 1-2 weeks 1
  • Titrate up to a maximum of 45 mg per day as needed 1, 2
  • The elimination half-life of 20-40 hours supports once-daily dosing 3, 4

Pharmacological Considerations

  • Mirtazapine has a unique mechanism of action as a noradrenergic and specific serotonergic antidepressant (NaSSA) 5
  • It blocks presynaptic alpha-2 adrenergic receptors and postsynaptic serotonin 5-HT2 and 5-HT3 receptors 3
  • Bioavailability is approximately 50%, with peak plasma concentrations reached within 2-3 hours 5, 4
  • Steady state is typically reached within 4-6 days of consistent dosing 4

Dose Modifications

  • Patients with hepatic or renal impairment may require lower doses due to decreased clearance 4
  • Strong CYP3A inducers (e.g., carbamazepine, phenytoin, rifampin) may necessitate higher mirtazapine doses 1
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) may require lower mirtazapine doses 1
  • Cimetidine co-administration may require dose reduction of mirtazapine 1

Clinical Pearls

  • Therapeutic effects on depression typically begin in 2-4 weeks, though sleep and anxiety symptoms may improve within the first week 3
  • Lower doses (7.5-15 mg) may be more sedating than higher doses due to the predominance of histamine H1 receptor blockade at lower doses 6, 7
  • Higher doses (30-45 mg) may have more noradrenergic effects and potentially less sedation 7
  • Common side effects include somnolence/sedation (23%), dry mouth (25%), increased appetite (11%), and weight gain (10%) 8, 7

Discontinuation

  • Gradually taper the dose rather than stopping abruptly to minimize discontinuation symptoms 1
  • Monitor for withdrawal symptoms during dose reduction 1

Special Considerations

  • Screen for bipolar disorder prior to initiating treatment 1
  • Allow at least 14 days between discontinuing MAOIs and starting mirtazapine, and vice versa 1
  • Mirtazapine appears to have a very low potential for inducing seizures, making it potentially safer in patients with seizure disorders 5, 7

By following this dosing regimen and considering these clinical factors, mirtazapine can be effectively used to treat depression while minimizing adverse effects and optimizing therapeutic outcomes.

References

Guideline

Mirtazapine for Anxiety and Depression: Efficacy and Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of mirtazapine.

Clinical pharmacokinetics, 2000

Guideline

Mirtazapine Treatment Guidelines for Major Depressive Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.